Keywords: Novo nordisk
The Eli Lilly and Co weight-loss pill has received approval from the U.S. Food and Drug Administration, marking a major step in the growing market for oral obesity treatments. The drug, called orforglipron and marketed under the brand name Foundayo, becomes the second pill-based option available in the......
Marrakesh, November 4, 2025 — The pharmaceutical company Novo Nordisk, in partnership with Laprophan Laboratories, has officially launched Semaglutide in Morocco — an innovative medication designed for patients with type 2 diabetes. The announcement was made......
Morocco ranks among the top 10 countries with the highest prevalence of type 1 diabetes in children, with over 43,000 cases reported in individuals under the age of 19. In a significant step to address this pressing health issue, Danish pharmaceutical company Novo Nordisk and the Moroccan Society for......
-
08:32
-
08:30
-
08:16
-
08:15
-
08:00
-
07:57
-
07:45
-
07:41
-
07:30
-
07:25
-
07:15
-
07:10
-
07:00
-
06:57
-
20:20
-
20:15
-
20:00
-
19:50
-
19:45
-
19:31
-
19:30
-
19:17
-
19:15
-
19:00
-
18:52
-
18:45
-
18:35
-
18:30
-
18:18
-
18:18
-
18:15
-
18:01
-
18:00
-
17:45
-
17:30
-
17:15
-
17:00
-
16:47
-
16:45
-
16:30
-
16:30
-
16:16
-
16:15
-
16:00
-
15:52
-
15:45
-
15:36
-
15:30
-
15:21
-
15:15
-
15:10
-
15:00
-
14:59
-
14:45
-
14:45
-
14:30
-
14:29
-
14:15
-
14:14
-
14:00
-
13:53
-
13:46
-
13:45
-
13:42
-
13:31
-
13:30
-
13:15
-
13:13
-
13:00
-
12:45
-
12:31
-
12:31
-
12:16
-
12:15
-
12:00
-
12:00
-
11:45
-
11:42
-
11:30
-
11:28
-
11:25
-
11:24
-
11:15
-
11:11
-
11:06
-
11:00
-
11:00
-
10:50
-
10:45
-
10:45
-
10:45
-
10:38
-
10:38
-
10:31
-
10:30
-
10:29
-
10:20
-
10:18
-
10:15
-
10:11
